Style | Citing Format |
---|---|
MLA | Heidarzadehpilehrood R, et al.. "A Review on Cyp11a1, Cyp17a1, and Cyp19a1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (Pcos) and Infertility." Genes, vol. 13, no. 2, 2022, pp. -. |
APA | Heidarzadehpilehrood R, Pirhoushiaran M, Abdollahzadeh R, Osman MB, Sakinah M, Nordin N, Hamid HA (2022). A Review on Cyp11a1, Cyp17a1, and Cyp19a1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (Pcos) and Infertility. Genes, 13(2), -. |
Chicago | Heidarzadehpilehrood R, Pirhoushiaran M, Abdollahzadeh R, Osman MB, Sakinah M, Nordin N, Hamid HA. "A Review on Cyp11a1, Cyp17a1, and Cyp19a1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (Pcos) and Infertility." Genes 13, no. 2 (2022): -. |
Harvard | Heidarzadehpilehrood R et al. (2022) 'A Review on Cyp11a1, Cyp17a1, and Cyp19a1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (Pcos) and Infertility', Genes, 13(2), pp. -. |
Vancouver | Heidarzadehpilehrood R, Pirhoushiaran M, Abdollahzadeh R, Osman MB, Sakinah M, Nordin N, et al.. A Review on Cyp11a1, Cyp17a1, and Cyp19a1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (Pcos) and Infertility. Genes. 2022;13(2):-. |
BibTex | @article{ author = {Heidarzadehpilehrood R and Pirhoushiaran M and Abdollahzadeh R and Osman MB and Sakinah M and Nordin N and Hamid HA}, title = {A Review on Cyp11a1, Cyp17a1, and Cyp19a1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (Pcos) and Infertility}, journal = {Genes}, volume = {13}, number = {2}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Heidarzadehpilehrood R AU - Pirhoushiaran M AU - Abdollahzadeh R AU - Osman MB AU - Sakinah M AU - Nordin N AU - Hamid HA TI - A Review on Cyp11a1, Cyp17a1, and Cyp19a1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (Pcos) and Infertility JO - Genes VL - 13 IS - 2 SP - EP - PY - 2022 ER - |